The Skinny on Weight Loss Drugs

Double Take By Newton

English - September 12, 2023 11:00 - 40 minutes - 27.9 MB
Investing Business News Business News asset management investment management investing markets economics Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Demography in the Fourth Turning

Next Episode: The Insurance Climate

As the obesity epidemic rages across the globe, new weight loss drugs have become so popular that some manufacturers are unable to meet patient demand. Dr. David Katz, founder and CEO of Diet ID, joins Double Take to discuss investment ramifications of these hotly demanded medications.